Search for a research project
Other search option(s)
250 Result(s)
Funded by an IRDiRC member = 
Member of a ERN = 
Research projects
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An Observational Long-Term Safety Surveillance Study of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
Lung microbiome for screening imminent exacerbation in CF (cystic fibrosis)
Medizinische Universität Wien
Forschungslabor Infektionsbiologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
PAPED: Cross Transmissions of Pseudomonas Aeruginosa in a Pediatric Cohort Followed-up at the Cystic Fibrosis Reference Center of the Queen Fabiola Children's University Hospital
Hôpital Universitaire des Enfants Reine Fabiola - HUDERF
Service de Pneumologie-Allergologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
FLONAMUC: Epidemiology of the Nasal Flora at the Reference Center for Cystic Fibrosis of Queen Fabiola Children's University Hospital
Hôpital Universitaire des Enfants Reine Fabiola - HUDERF
Service de Pneumologie-Allergologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MucoSWEATomics New Markers of CFTR Function in Sweat: Value for Diagnosis and Efficacy of Target Therapies
Université Catholique de Louvain (UCL)
Louvain centre for Toxicology and Applied Pharmacology
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES
Efflux as a mechanism of intrinsic and acquired resistance to antibiotics in Achromobacter xylosoxidans
Cellular and Molecular Pharmacology Unit, Louvain Drug Research Institute, UCL
Cellular and Molecular Pharmacology Unit
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES
Development of CFTR-stabilizers as therapeutic for cystic fibrosis
Structure et Fonction des Membranes Biologiques
Laboratoire Structure et Fonction des Membranes Biologiques
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES
Development of diagnosic immuno-assays to detect atypical mycobacteria in patients with Cystic Fibrosis and investigation of its potential for monitoring treatment success
Université Libre de Bruxelles
BELGIUM
OOST-VLAANDEREN
GENT
Developing a personalized approach for antimicrobial susceptibility testing in cystic fibrosis
LPM Pharmaceutical Microbiology, Universiteit Gent
LPM Laboratory of Pharmaceutical Microbiology
BELGIUM
VLAAMS BRABANT
LEUVEN
Development of drug based therapies to target rare mutations causing severe cystic fibrosis
Center for molecular medicine, Division of Molecular Virology and Gene Therapy
Molecular Virology and Gene Therapy
BELGIUM
VLAAMS BRABANT
LEUVEN
Dynamics of cystic fibrosis airway microbiota: application of next-generation sequencing in a long-term cohort study to characterize bacterial and viral components prior to and during acute exacerbations
Rega (KU Leuven)
Laboratorium Klinische en Epidemiologische Virologie (Rega Instituut)
BELGIUM
VLAAMS BRABANT
LEUVEN
Evaluation of CFTR function in cultured organoids from rectal biopsies in patients with Cystic Fibrosis
UZ Leuven - Campus Gasthuisberg
Dienst Kindergeneeskunde/Department of Pediatrics
BELGIUM
VLAAMS BRABANT
LEUVEN
Dynamics of cystic fibrosis airway microbiota: application of next-generation sequencing in a long-term cohort study to characterize bacterial and viral components prior to and during acute exacerbations
UZ Leuven - Campus Gasthuisberg
Pneumology department
BELGIUM
VLAAMS BRABANT
LEUVEN
The endothelium as the central mediator of cystic fibrosis associated liver disease
UZ Leuven - Campus Gasthuisberg
UZ Leuven
CANADA
Colombie-Britannique
VANCOUVER
Mechanisms of Hyperinfammation in Cystic Fibrosis
Centre for Microbial Diseases and Immunity Research
CANADA
Nouvelle-Écosse
HALIFAX
Functional Architecture of the CFTR Chloride Channel
Dalhousie University
Department of Physiology & Biophysics
CANADA
Nouvelle-Écosse
HALIFAX
Regulation of CFTR membrane stability and function by VIP
Dalhousie University
Department of Physiology & Biophysics
CANADA
Ontario
TORONTO
Evaluating the Mechanism of Action of Small Molecule Modulators of CFTR
Hospital for Sick Children, Research Institute
CANADA
Ontario
TORONTO
Pathophysiology of Cystic Fibrosis Lung Disease
Hospital for Sick Children, Research Institute
Paediatric Laboratory Medicine
CANADA
Ontario
TORONTO
Ensuring effective newborn screening: The case of cystic fibrosis
University of Toronto
Institute of Health Policy, Management and Evaluation
CANADA
Québec
MONTRÉAL
Screening for abnormalities related to glucose tolerance secondary to cystic fibrosis
Institut de recherches cliniques de Montréal
Plateforme de recherche en obésité, métabolisme et diabète
CANADA
Québec
SAINTE FOY
Pim1, a new biomarker predicting severity, prognosis and response to interventions in diverse types of pulmonary hypertension characterized by pulmonary vascular remodeling
Hôpital Laval
Institut universitaire de cardiologie et de pneumologie de Québec
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
Understanding the mechanisms of self-suppression of secreton 3 of Pseudomonas aeruginosa by catabolites of tryptophan, the influence on interactions bacteria / host and therapeutic perspectives of cystic fibrosis
Faculté de médecine de Grenoble
Equipe TheREx (Thérapeutique Recombinante Expérimentale)
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
B9inPAH: BMP9 as a major regulator of vascular tone in Pulmonary Arterial Hypertension: a promising new therapeutic target - FR
Institut de Biosciences et Biotechnologies de Grenoble (BIG) - CEA
Laboratoire Biologie du Cancer et de l'Infection (BCI) - UMR 1036
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
Search for inhibitors of soluble lectins PA-IL and PA-IIL of Pseudomonas aeruginosa to nonstick therapy of cystic fibrosis
Université Joseph Fournier
Equipe "Glycologie Moléculaire"
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
Muscular function & cystic fibrosis
Université Joseph Fournier
Laboratoire de Recherche Exercice-Santé
FRANCE
BOURGOGNE-FRANCHE-COMTE
BESANÇON
Loss of efflux of MexAB-OprM type, a key element in the adaptation of Pseudomonas aeruginosa in chronic lung infection and cystic fibrosis
CHRU de Besançon - Hôpital Jean Minjoz
Laboratoire de bactériologie
FRANCE
BRETAGNE
BREST
Study of the involvement of pulmonary neuroendocrine cells in cystic fibrosis
CHU de Brest - Hôpital de la Cavale Blanche
Laboratoire de génétique moléculaire et d'histocompatibilité
FRANCE
CENTRE-VAL DE LOIRE
ORLEANS
Cellular and molecular interactions between proteins E3-14.7K / FIP-1 and microtubules in cystic fibrosis
Centre de biophysique moléculaire
Glycobiologie vectorologie et trafic intracellulaire
FRANCE
CENTRE-VAL DE LOIRE
TOURS
Induction of neutrophilic traps (NETs) by the inflammation and infectious pulmonary environment of cystic fibrosis
Faculté de pharmacie de Tours
Unité INSERM U618 "Protéases et Vectorisation Pulmonaires"
FRANCE
CENTRE-VAL DE LOIRE
TOURS
Identification of ligands of human lung cells and production of vectors derived from HPV to lung targeting in cystic fibrosis
Faculté de pharmacie de Tours
Unité INSERM U618 "Protéases et Vectorisation Pulmonaires"
FRANCE
GRAND-EST
REIMS
Does the mutation of the CFTR contributes to the bone fragility in cystic fibrosis?
Université de Reims - UFR des sciences exactes et naturelles
INSERM UMR-S 926 "Interfaces Biomatériaux / Tissus Hôtes"
FRANCE
HAUTS-DE-FRANCE
VILLENEUVE D'ASCQ
Regulation and control of the biosynthesis of sialyl Lewisx and 6-sulfo sialyl Lewisx, ligands of Pseudomonas aeruginosa in human bronchial mucosa in cystic fibrosis
Faculté des Sciences et Technologies - Université de Lille
UGSF - Unité de glycobiologie structurale et fonctionnelle
FRANCE
HAUTS-DE-FRANCE
VILLENEUVE D'ASCQ
Study of the expression and the glycosylation of DMBT1 by the parietal glycoconjugates (LPS and alginate) of Pseudomonas aeruginosa from patients with cystic fibrosis
Faculté des Sciences et Technologies - Université de Lille
UGSF - Unité de glycobiologie structurale et fonctionnelle
FRANCE
ILE-DE-FRANCE
CRÉTEIL
Contribution to the study of the CFTR interactome: dynamics and role of a CFTR-containing complex in inflammation in cystic fibrosis
Faculté de Médecine de Créteil
Equipe "Immunopathologie rénale et immunomodulation en transplantation"
FRANCE
ILE-DE-FRANCE
GARCHES
Mycobacterium abscessus - phagocytic cells CFTR-/ - and particular susceptibility of CF patients
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de microbiologie
FRANCE
ILE-DE-FRANCE
LE PLESSIS-ROBINSON
CoVeR: Contribution of the Vascular Smooth Muscle Cell-associated Type I cytokine receptors to Pulmonary Arterial Hypertension: At the interface between inflammation and pulmonary vascular remodeling
Centre Chirurgical Marie Lannelongue
Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique - Inserm UMR_S 999
FRANCE
ILE-DE-FRANCE
ORSAY
Alternative to antibiotics: phenotypic and genetic study of active phages on strains of P. aeruginosa and S. aureus infecting children with cystic fibrosis
Université Paris-Sud
Département évolution et phylogénie moléculaire
FRANCE
ILE-DE-FRANCE
PARIS
Implementation of non-invasive prenatal diagnosis of rare and severe monogenic diseases
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de génétique et biologie moléculaires
FRANCE
ILE-DE-FRANCE
PARIS
Assessment of perfusion pressures on introduced catheter chamber in adult patients with cystic fibrosis
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de pneumologie - CRCM
FRANCE
ILE-DE-FRANCE
PARIS
Tracheal malformations in cystic fibrosis: fundamental studies and clinical investigation
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Service de pneumologie pédiatrique
FRANCE
ILE-DE-FRANCE
PARIS
Indications and benefits of nocturnal oxygen therapy in cystic fibrosis
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Service de pneumologie pédiatrique
FRANCE
ILE-DE-FRANCE
PARIS
Central ventilatory control in patients with chronic obstructive pulmonary disease: anatomical and functional brain imaging with functional nuclear magnetic resonance
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Service de pneumologie A
FRANCE
ILE-DE-FRANCE
PARIS
Modulation of alveolar macrophage and bronchial epithelial cells function by the antimicrobial/antelastase elafin molecule in cystic fibrosis patients
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et Epidémiologie des Maladies respiratoire - INSERM UMR 1152
FRANCE
ILE-DE-FRANCE
PARIS
Structural and functional studies of OprN/Mexe/MexF and OprM/MexC/MexD efflux pumps involved in antibiotic resistance in Pseudomonas aeruginosa in cystic fibrosis patients
Faculté de médecine Paris-Descartes, Site Necker
Laboratoire de Cristallographie & RMN biologiques
FRANCE
ILE-DE-FRANCE
PARIS
NEUPROCF: new diagnostic and prognostic biomarkers in cystic fibrosis (coordination)
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"
FRANCE
ILE-DE-FRANCE
PARIS
Genotype-phenotype study of CFTR from a new model of human respiratory epithelium of cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"
FRANCE
ILE-DE-FRANCE
PARIS
Validation of the assessment of bone mineralization by quantitative computed tomography in patients with cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"
FRANCE
ILE-DE-FRANCE
PARIS
Virulence of Mycobacterium abscessus: role of surface glycopeptidolipids in cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Analyse génétique de l'enveloppe mycobactérienne
FRANCE
ILE-DE-FRANCE
PARIS
Prospective study of the psychopathology of adolescents with cystic fibrosis
Hôpital Necker-Enfants Malades
Unité de pneumo-allergologie pédiatrique
FRANCE
ILE-DE-FRANCE
PARIS
Three-dimensional structure modeling of CFTR: predicting the impact of mutations and binding sites of markers / potentiators in cystic fibrosis patients
IMPMC - Institut de Minéralogie et de Physique des Milieux Condensés
Protein Structure Prediction
FRANCE
ILE-DE-FRANCE
PARIS
Development of a novel site specific recombination system for safer gene therapy for the treatment of cystic fibrosis
Institut Pasteur
Département de microbiologie
FRANCE
ILE-DE-FRANCE
VERSAILLES
Highlight CNG cation channels (cyclic nucleotide-gated cation channels) in the bronchial epithelium and bronchiolar airways of human with cystic fibrosis or not
Université de Versailles Saint-Quentin
Laboratoire Mécanismes pharmacologiques et moléculaires de l' obstruction bronchique
FRANCE
ILE-DE-FRANCE
VILLEJUIF
Transition Platforms: Understanding the Expectations of Parents of Young People with Rare Diseases
CLCC Institut Gustave Roussy
Equipe Epidémiologie des radiations, épidémiologie clinique des cancers et survie
FRANCE
NOUVELLE AQUITAINE
POITIERS
Study the relationship between the relocation of F508del-CFTR and the normalization of calcium signaling in cystic fibrosis patients
Université de Poitiers
Institut de Physiologie et Biologie Cellulaires
FRANCE
OCCITANIE
MONTPELLIER
Measuring the impact of surgery on nasosinusienne ENT symptoms and sleep quality in patients with cystic fibrosis
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Service des maladies respiratoires
FRANCE
OCCITANIE
MONTPELLIER
DNA glycomimetics to prevent the adherence of Pseudomonas aeruginosa - impact in cystic fibrosis
Faculté de Pharmacie
Département oligonucléotides modifiés
FRANCE
OCCITANIE
MONTPELLIER
Study of CFTR gene's transcriptional regulation in cystic fibrosis
IURC - Institut Universitaire de Recherche Clinique
Laboratoire de génétique moléculaire
FRANCE
OCCITANIE
MONTPELLIER
UMD-CFTR knowledgebase: outils informatiques pour la prédiction et la validation d'hypothèses biologiques potentiellement intéressantes en thérapie dans la mucoviscidose
IURC - Institut Universitaire de Recherche Clinique
Laboratoire de génétique moléculaire
FRANCE
OCCITANIE
MONTPELLIER
Identification of new regulatory actors in the noncoding regions of CFTR gene: the microRNA and cystic fibrosis
IURC - Institut Universitaire de Recherche Clinique
Laboratoire de génétique moléculaire
FRANCE
OCCITANIE
MONTPELLIER
Study of virulence factor MGTC and its inhibition by a natural peptide in Pseudomonas aeruginosa and in non-tuberculous mycobacteria - impact in cystic fibrosis
Université Montpellier II
Laboratoire de dynamique des interactions membranaires normales et pathologiques - Case 107
FRANCE
OCCITANIE
TOULOUSE
Effect of CFTR on the intra-enterocyte cholesterol in patients with cystic fibrosis
CHU de Toulouse - Hôpital Purpan
Département lipoprotéines et médiateurs lipidiques
FRANCE
PAYS DE LA LOIRE
NANTES
CFTR gene expression in the pulmonary epithelium by targeted gene transfer in cystic fibrosis
Faculté de médecine de Nantes
Physiopathologie et pharmacologie cellulaire et moléculaire
FRANCE
PAYS DE LA LOIRE
NANTES
Reduced lung inflammation in cystic fibrosis by inhibiting the expression of key genes by RNA interference
Faculté de médecine de Nantes
Physiopathologie et pharmacologie cellulaire et moléculaire
GERMANY
Baden-Württemberg
HEIDELBERG
Association Between BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension Patients: an Explorative Cross-sectional Study
Thoraxklinik-Heidelberg gGmbH
Thoraxklinik Heidelberg
GERMANY
Baden-Württemberg
HEIDELBERG
COMPERA / COMPERA-KIDS: Prospective registry of newly initiated therapies for Pulmonary Hypertension
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde II - Pädiatrische Kardiologie/Angeborene Herzfehler
GERMANY
Baden-Württemberg
ULM
The TOPP-2 registry: Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
Klinik für Kinder- und Jugendmedizin des Universitätsklinikums Ulm
Sektion Pädiatrische Kardiologie
GERMANY
Berlin
BERLIN
CORD : Collaboration On Rare Diseases
Geschäftsstelle BIH
Berliner Institut für Gesundheitsforschung
GERMANY
Niedersachsen
HANNOVER
COMPERA / COMPERA-KIDS: Prospective registry of newly initiated therapies for Pulmonary Hypertension
Medizinische Hochschule Hannover
Klinik für Pneumologie
IRELAND
County Cork
CORK
Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Cork University Hospital
Department of Respiratory Medicine
IRELAND
County Dublin
DUBLIN
The natural history of cystic fibrosis liver disease - refining the phenotype
Children's Health Ireland @ Crumlin
Gastroenterology Department
IRELAND
County Dublin
DUBLIN
C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @ Crumlin
Gastroenterology Department
IRELAND
County Dublin
DUBLIN
SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
Inflammatory and Microbiological Implications of Pooling of Bronchoalvelar Lavage samples in Preschhol Children with Cystic Fibrosis (The Pool Study)
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
PALM Study: Protease Activity:Lung Measurement in Children with Cystic Fibrosis
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
The Role of Human Rhinovirus Infections in young children with Cystic Fibrosis- A Pilot Study
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
The Role of Exosomes in Cystic Fibrosis Airway Pathogenesis (RECAP)
Children's Health Ireland @ Crumlin
Respirology Department
IRELAND
County Dublin
DUBLIN
Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @ Temple Street
Cystic Fibrosis Clinic
IRELAND
County Dublin
DUBLIN
SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre
IRELAND
County Dublin
DUBLIN
C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre
IRELAND
County Dublin
DUBLIN
Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre
IRELAND
County Dublin
DUBLIN
Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre
IRELAND
County Dublin
DUBLIN
The Role of Exercise in the Management of Cystic Fibrosis
Dublin City University
MedEx Research Laboratory
IRELAND
County Dublin
DUBLIN
The natural history of cystic fibrosis liver disease - refining the phenotype
The Catherine McAuley Education & Research Centre
UCD School of Medicine
IRELAND
County Limerick
LIMERICK
SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
University Hospital Limerick
Cystic Fibrosis Clinic
IRELAND
County Limerick
LIMERICK
C-FORMS: Children's Follow up Orkambi Real world MBV Study
University Hospital Limerick
Cystic Fibrosis Clinic
IRELAND
County Limerick
LIMERICK
Inflammatory and Microbiological Implications of Pooling of Bronchoalvelar Lavage samples in Preschhol Children with Cystic Fibrosis (The Pool Study)
University Hospital Limerick
Cystic Fibrosis Clinic
IRELAND
County Limerick
LIMERICK
Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
University Hospital Limerick
Cystic Fibrosis Clinic
IRELAND
County Limerick
LIMERICK
Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
University Hospital Limerick
Cystic Fibrosis Clinic
ITALY
LAZIO
ROMA
Anti-inflammatory therapy with dexamethasone slow release in the control of lung inflammation in patients with Cystic Fibrosis
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Epatologia, Gastroenterologia e Nutrizione
ITALY
LAZIO
ROMA
Italian National Cystic Fibrosis Patient's Registry
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare
ITALY
LAZIO
ROMA
Improving quality standards in Italian laboratories performing genetic testing for rare diseases
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare
ITALY
LOMBARDIA
MILANO
RescueCFTRpreclinic: Cysteamine for the treatment of cystic fibrosis: a translational research project - IT
IRCCS Ospedale San Raffaele
Centro di Genomica, Bioinformatica e Biostatistica - Unità di Genetica Umana e Molecolare
ITALY
TOSCANA
SIENA
Mutational and functional genomic study in Vascular Malformations to delineate appropriate therapeutic strategies
Azienda Ospedaliera Universitaria Senese - Policlinico Santa Maria alle Scotte
U.O.C. di Genetica Medica
JAPAN
JAPAN
KYOTO
Multiomics analyses integrating genome/transcriptome/metabolome to elucidate the pathology of rare intractable diseases
Kyoto University Graduate School of Medicine
JAPAN
JAPAN
MIYAGI
Selenoprotein P Promotes Vascular Smooth Muscle Cell Proliferation and Pulmonary Hypertension-A Possible Novel Therapeutic Target-
Tohoku University Graduate School of Medicine
Department of Cardiovascular Medicine
JAPAN
JAPAN
OSAKA
Development of novel therapeutic strategies for pulmonary arterial hypertension targeting interleukin-2 1
National Cerebral and Cardiovascular Center
Department of Vascular Physiology
NORWAY
Østlandet
OSLO
Cystic Fibrosis and Fit-to-Fly
Oslo University Hospital, Ullevaal
NSCF - Norsk senter for cystisk fibrose
PORTUGAL
SUL
LISBOA
Elucidating the role of novel CFTR interactors - new mechanisms in membrane protein trafficking.
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit
PORTUGAL
SUL
LISBOA
Diagnosis, Prognosis and Treatment of Cystic Fibrosis
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit
PORTUGAL
SUL
LISBOA
Characterization of ER-quality control for the F508del-CFTR protein: potential therapeutic targets for cystic fibrosis
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit
PORTUGAL
SUL
LISBOA
Identification of Novel Targets Rescuing of F508del-CFTR Traffic: Mechanism of Action
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit
PORTUGAL
SUL
OEIRAS
Biochemical and Structural Studies of UDP-Glucose Dehydrogenases.
Instituto de Tecnologia Química e Biológica
Unidade de Cristalografia Macromolecular
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Improving diagnostic accuracy and therapeutic perspectives in interstitial lung diseases
IDIBELL - Instituto de Investigación Biomédica de Bellvitge
Grupo de Investigación en Neumología
SPAIN
Cataluña
SABADELL
Impact of viral respiratory infection on the gut-lung axis microbiome in cystic fibrosis
Corporación Sanitaria Parc Taulí. Hospital de Sabadell
Servicio de neumología
SWITZERLAND
Suisse Alémanique
BERN
Multiple Breath Washout in Children with Cystic Fibrosis: Transition from a Specialised Tool to Clinical Implementation
Inselspital Universitätsspital
Abteilung für pädiatrische Pneumologie und Allergologie
SWITZERLAND
Suisse Alémanique
BERN
Prospective Surveillance of Lung Development During Childhood, Adolescence and Adulthood in Healthy and Patients With Cystic Fibrosis
Inselspital Universitätsspital
Abteilung für pädiatrische Pneumologie und Allergologie
SWITZERLAND
Suisse Alémanique
BERN
Multiple-breath Washout for Lung Function Testing in Children With Cystic Fibrosis: Predictive for Survival?
University Hospital Inselspital
CF Zentrum Kinderspital Bern
SWITZERLAND
Suisse Alémanique
BERN
Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis
University Hospital Inselspital
CF Zentrum Kinderspital Bern
SWITZERLAND
Suisse Romande
GENÈVE
Intercellular signaling in cystic Fibrosis airway innate host defense mechanisms
Centre Médical Universitaire - CMU
Département de physiologie cellulaire et métabolisme
UNITED KINGDOM
Antrim and Newtownabbey
BELFAST
Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis (PRIVATE)
Queen's University Belfast
School of Medicine, Dentistry and Biomedical Sciences
UNITED KINGDOM
Avon
BRISTOL
EUROCARE CF: European coordination action for research in cystic fibrosis (coordination)
University of Bristol
Department of Physiology and Pharmacology
UNITED KINGDOM
Greater London
LONDON
Air Pollution and Children With Cystic Fibrosis -GB
Queen Mary University of London Headquarters
UNITED KINGDOM
Greater Manchester
MANCHESTER
Connecting Lung Structure and Function in Cystic Fibrosis Through Physiological Modelling, Image Analysis, and Uncertainty Quantification
The University of Manchester
School of Biological Sciences
UNITED KINGDOM
Hampshire
PORTSMOUTH
Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers. (EXHALE 1B)
Portsmouth Hospital
Queen Alexandra Hospital
UNITED KINGDOM
Lothian
EDINBURGH
Inflammation in Cystic Fibrosis Lung Disease: Defining the Role of Calprotectin
Western General Hospital
Edinburgh Cancer Research Centre
UNITED KINGDOM
Warwickshire
COVENTRY
Building and dismantling polymicrobial pathogen communities in cystic fibrosis.
University of Warwick
School of Life Sciences
UNITED STATES
Maryland
BETHESDA
Identification of Novel Targets Rescuing of F508del-CFTR Traffic: Mechanism of Action
Cystic Fibrosis Foundation
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Azithromycin in cystic fibrosis: microbiologic and functional impact of potent anti-pseudomonal activity on inflammation
Institution: Information not provided - US
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
Role of sclerostin in pulmonary arterial hypertension
Institution: Information not provided - AT
GERMANY
Baden-Württemberg
HEIDELBERG
Yoga in Patients With Fibrosing Interstitial Lung Diseases
Thoraxklinik-Heidelberg gGmbH
Thoraxklinik Heidelberg
GERMANY
Bayern
MÜNCHEN
HCQ4Surfdefect : Hydroxychloroquine (HCQ) in pediatric ILD -DE-
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Christiane Herzog Ambulanz
SPAIN
Madrid
MADRID
Genetic-molecular bases of precision medicine in pulmonary arterial hypertension
Hospital Universitario 12 de Octubre
Unidad Multidisciplinar de Hipertensión Pulmonar
SPAIN
Madrid
MADRID
GENETIC PASSIONHP Project
INGEMM - Instituto de Genética Médica y Molecular (IdiPAZ)
Sección de Genómica Estructural y Funcional
FRANCE
ILE-DE-FRANCE
LE PLESSIS-ROBINSON
TAMIRAH: Targeting activated mineralocorticoid receptor in Pulmonary Arterial Hypertension: A translational approach towards treatment - FR
Centre Chirurgical Marie Lannelongue
Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique - Inserm UMR_S 999
SPAIN
Madrid
MADRID
Role of hypoxia and inflammation in the dysfunction of endothelial progenitor cells in pediatric pulmonary hypertension
Universidad Complutense de Madrid. Facultad de Medicina
Departamento de Farmacología y Toxicología
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset disease
Institution: Information not provided - US
AUSTRIA
WIEN
WIEN
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With Severe Acute Respiratory Distress Syndrome and Veno-venous Extracorporeal Membrane Oxygenation: a Prospective, Randomized, Clinical Trial
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Allgemeine Anästhesie und Intensivmedizin
AUSTRIA
WIEN
WIEN
ALARM: Advisory Lead ARDS Respirator Management
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Allgemeine Anästhesie und Intensivmedizin
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Unravelling POIKTMP pathophysiology for design of therapeutic approaches
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
BRON
Transmission génétique des formes familiales de sarcoidose
CHU de Lyon HCL - GH Est
Unité Médicale de Génétique des Cancers et des Maladies Multifactorielles
FRANCE
AUVERGNE-RHONE-ALPES
BRON
Transmission génétique des formes familiales de sarcoidose
CHU de Lyon HCL - GH Est-Hôpital Louis Pradel
Service de pneumologie
GERMANY
Berlin
BERLIN
Surface electromyography in patients with Acute Respiratory Distress Syndrome (ARDS)
Charité - Universitätsmedizin Berlin (CBF)
Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin
HUNGARY
Dél-Dunántúl
PECS
Studying the role of Wnt signaling to develop novel therapeutic targets and diganostic markers in LAM
University of Pécs
Department of Pharmacological Biotechnology
IRELAND
County Galway
GALWAY
Development of a nebulised cell based therapy for acute respiratory distress syndrome
National University of Ireland Galway
School of Medicine
JAPAN
JAPAN
SHIZUOKA
Development of cloud-based integrated database and interactive diagnosis system for improving diagnostic accuracy and providing evidence for idiopathic interstitial pneumonias
Hamamatsu University School of Medicine
NETHERLANDS
Utrecht
NIEUWEGEIN
Genetic predisposition to interstitital lung diseases and disease phenotypes
St. Antonius Ziekenhuis, locatie Nieuwegein
Longcentrum
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Inhaled gm-csf therapy of autoimmune pulmonary alveolar proteinosis
Institution: Information not provided - US
AUSTRIA
TIROL
INNSBRUCK
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis - AT
Medizinische Universität Innsbruck
Pädiatrie I
AUSTRIA
WIEN
WIEN
STRIVE: A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Nephrologie und Gastroenterologie
CANADA
Ontario
KINGSTON
IIH-ECC: Idiopathic Infantile Hypercalcemia - European-Canadian Consortium -CA
Queen's University
Department of Biomedical and Molecular Sciences
CANADA
Ontario
TORONTO
The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Hospital for Sick Children, Research Institute
CANADA
Québec
MONTRÉAL
Role of SMPD1 in respiratory infections in Niemann-Pick type A/B disease
Meakins-Christie Laboratories
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
USIDNET: modelization of X+CGD chronic granulomatous disease and Nox2 super oxidase mutants in the PLB-985 cell line to study the NADPH oxidase activation process
CHU de Grenoble et des Alpes - Institut de biologie et de pathologie
Centre Diagnostic et Recherche sur la Granulomatose Septique Chronique
FRANCE
AUVERGNE-RHONE-ALPES
LA TRONCHE
NOX NADPH oxydases in inflammatory response: physiopathological aspects, regulation mechanism and modeling
Université Grenoble Alpes (UGA) - Campus santé
GREPI : Groupe de Recherche et d'Etudes du Processus Inflammatoire
FRANCE
AUVERGNE-RHONE-ALPES
LA TRONCHE
Validation of a new concept of cell therapy by transfer of proteins in enzymopathies: application to the Chronic septic granulomatosis
Université Grenoble Alpes (UGA) - Campus santé
GREPI : Groupe de Recherche et d'Etudes du Processus Inflammatoire
FRANCE
CENTRE-VAL DE LOIRE
TOURS
Acoustic Waves and Helium/oxygen for Aerosol Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Faculté de Médecine, Université de Tours François Rabelais
Équipe Inserm 3 : « Aérosolthérapie et biothérapies à visée respiratoire »
FRANCE
GRAND-EST
STRASBOURG CEDEX
Rare Invisible Disease and Schooling of Children
ESPE de Strasbourg
Equipe Apprentissages, pratiques d'enseignement et d'éducation
FRANCE
ILE-DE-FRANCE
CRÉTEIL
Surfactant deficiencies in chronic lung diseases in children
Centre Hospitalier Intercommunal de Créteil
Service de pédiatrie - Hôpital de jour
FRANCE
ILE-DE-FRANCE
PARIS
ERADAS and ERAFI: development and validation of the scores of activity and functional impairment in juvenile spondylitis
Hôpital Necker-Enfants Malades
Développement normal et pathologique du système immunitaire
GERMANY
Bayern
GAUTING
INSIGHTS-IPF: Investigating significant health trends in Idiopathic Pulmonary Fibrosis. Nationwide Prospective Registry
Asklepios-Fachkliniken München-Gauting
Klinik für Pneumologie
GERMANY
Berlin
BERLIN
ICON: Long-term course of juvenile idiopathic arthritis - long-term studies in health research
Deutsches Rheuma-Forschungszentrum Berlin
Forschungsbereich Epidemiologie
GERMANY
Berlin
BERLIN
JuMBO: Juvenile Arthritis - Methotrexate / Biologics long-term Observation
Deutsches Rheuma-Forschungszentrum Berlin
Forschungsbereich Epidemiologie
GERMANY
Hessen
GIEßEN
KFO 309: Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies : Role of epithelial endoplasmic reticulum stress and epithelial FGF signaling in the initiation and aggravation of lung fibrosis by viral infection (P7)
Med. Klinik und Poliklinik II des UKGM am Standort Gießen
Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen
GERMANY
Nordrhein-Westfalen
MÜNSTER
ICON: Long-term course of juvenile idiopathic arthritis - long-term studies in health research
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Rheumatologie und Immunologie
GERMANY
Nordrhein-Westfalen
SANKT AUGUSTIN
BIKER Registry: Long-term observation of the efficacy and tolerability of biologics for the treatment of patients with Juvenile Idiopathic Arthritis
Asklepios Kinderklinik Sankt Augustin GmbH
Abteilung für Allgemeine Kinder- und Jugendmedizin
IRELAND
County Dublin
DUBLIN
Evaluating the role of TLR3 L412F in disease progression in idiopathic pulmonary fibrosis
Trinity College Dublin
Institute of Molecular Medicine
IRELAND
County Dublin
DUBLIN
Urinary sCD163 as a biomarker in crescentic glomerulonephritis
Trinity College Dublin
Trinity Translational Medicine Institute
IRELAND
County Galway
GALWAY
Lending an ear: "iPeer2Peer" plus "Teens Taking Charge" Online Self-Management to empower children with arthritis
National University of Ireland Galway
Centre for Pain Research
ITALY
EMILIA ROMAGNA
BOLOGNA
Combined Evaluation of Pulmonary Fluids by Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress Syndrome
Policlinico S. Orsola-Malpighi - Area S. Orsola
Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi
ITALY
LIGURIA
GENOVA
PHARMACHILD: PHARMACOVIGILANCE IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AGENTS AND/OR METHOTREXATE
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II
ITALY
LIGURIA
GENOVA
The PRINTO Evidence-based Revision of the International League Against Rheumatism (ILAR) Classification criteria for juvenile idiopathic Arthritis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II
ITALY
LOMBARDIA
MILANO
Combined Evaluation of Pulmonary Fluids by Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress Syndrome
ASST Grande Ospedale Metropolitano Niguarda
Ospedale Niguarda
ITALY
LOMBARDIA
MILANO
Pathogenesis and therapy of chronic granulomatous disease by gene transfer into hematopoietic stem cells
Istituto San Raffaele Telethon per la Terapia Genica - TIGET
Unità di Ricerca Clinica
ITALY
LOMBARDIA
MONZA
Nutritional Assessment in Idiopathic Pulmonary Fibrosis: a Pilot Study
ASST Monza - Ospedale San Gerardo
Dipartimento Cardio-Toraco-Vascolare
ITALY
LOMBARDIA
MONZA
Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis (CardioIPF)
ASST Monza - Ospedale San Gerardo
Dipartimento Cardio-Toraco-Vascolare
JAPAN
JAPAN
KYOTO
Discovery of novel therapeutic approach for Nakajo-Nishimura syndrome and Blau syndrome
Center for iPS Cell Research and Application, Kyoto University
Department of Clinical Application
JAPAN
JAPAN
TOKYO
Promotion of Japanese IgA nephropathy prospective cohort study to improve the reliability and validity of Japanese classifications of histological grade, clinical severity and dialysis induction risk; the development of treatment to protect high risk patients from progression to end-stage kidney disease
The Jikei University Hospital
Clinical Training Center
SPAIN
Andalucía
CÓRDOBA
Identification of molecular heterogeneity associated with cardiovascular disease, clinical course and therapeutic response in systemic autoimmune diseases
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba
GC05 - Grupo de investigación en enfermedades autoinmunes inflamatorias sistémicas y crónicas del aparato locomotor
SPAIN
Asturias
OVIEDO
Response polymorphisms in relation to pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
Hospital Universitario Central de Asturias
Servicio de Neumología
SPAIN
Baleares
PALMA DE MALLORCA
Cell therapy in an experimental model of pulmonary fibrosis with telomere shortening and characterization of pulmonary MSC in IPF with telomere shortening
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
Grupo de investigación en Inflamación, reparación y cáncer en enfermedades respiratorias
SPAIN
Cantabria
SANTANDER
Characterization of molecular bases of IgA-mediated vasculitis
IDIVAL: Instituto de Investigación Marqués de Valdecilla
Grupo de Epidemiología genética y arterioesclerosis en enfermedades inflamatorias sistémicas
SPAIN
Cataluña
BARCELONA
Study of pulmonary fibrosis using the "radio-transcriptome": a new way of evaluating interstitial fibrosing lung diseases
Hospital Clínic de Barcelona
Servicio de Neumología y Alergia Respiratoria
SPAIN
Cataluña
BARCELONA
Study of mechanisms of progression to pulmonary fibrosis in patients with hypersensitivity pneumonitis
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación en neumología
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Characterization of telomeric pulmonary fibrosis and its biological regulation
Hospital Universitari de Bellvitge
Servicio de Neumología
SPAIN
Madrid
ALCORCÓN
Deciphering the role of factor-H related proteins in complement-related kidney diseases
Hospital Universitario Fundación Alcorcón
Servicio de Nefrología
SPAIN
Madrid
MADRID
Deciphering the role of factor-H related proteins in complement-related kidney diseases
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Nefrología Clínica
SWEDEN
Region Stockholm
STOCKHOLM
Programmed cell clearance: molecular mechanisms and role in pathogenesis and treatment of chronic inflammation
Karolinska Institutet - Solna
The Institute of Environmental Medicine
SWITZERLAND
Suisse Alémanique
BASEL
Fibrosis-specific lung progenitor cells: Role and therapeutic potential in Idiopathic Pulmonary Fibrosis
Universitätsspital Basel
Klinik für Pneumologie
UNITED KINGDOM
Greater London
LONDON
Sub-phenotyping in juvenile dermatomyositis (JDM), a rare and serious autoimmune childhood disorder, within the UK JDM Cohort and Biomarker Study: from phenotype to stratified treatments
GOSH NHS Foundatin Trust
Juvenile Dermatomyositis Research Centre
UNITED KINGDOM
Greater London
LONDON
Development of an assessment tool for the measurement of fatigue and endurance in children with Juvenile Dermatomyositis
GOSH NHS Foundatin Trust
Rheumatology Unit
UNITED KINGDOM
Greater London
LONDON
An international survey of physiotherapy interventions in the management of Juvenile Dermatomyositis
GOSH NHS Foundatin Trust
Rheumatology Unit
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Juvenile myositis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Neuro-ophthalmic mechanisms of disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Drugs; germs; and joints: antibiotics; gut microbiota; and juvenile idiopathic arthritis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Animal care: supporting research on pathogenesis and treatment of autoimmunity
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Targeting jak3 in the treatment of autoimmune disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Acid sphingomyelinase and niemann-pick disease
Institution: Information not provided - US
AUSTRIA
WIEN
WIEN
From AAV (ANCA-associated vasculitis) to chronic kidney disease - contribution of TenascinC
Medizinische Universität Wien
Klinisches Institut für Pathologie
AUSTRIA
WIEN
WIEN
Extracellular Vesicles (EV) as markers of active disease in AAV (ANCA-associated vasculitis) - AT
Medizinische Universität Wien
Klinisches Institut für Pathologie
AUSTRIA
WIEN
WIEN
Computer assisted morphometry of pathological changes in renal biopsies from patients with AAV (ANCA-associated vasculitis) - AT
TissueGnostics GmbH - Headquarter
TissueGnostics GmbH
FRANCE
GRAND-EST
ILLKIRCH-GRAFFENSTADEN
Targeting the vitamin D receptor for the treatment of rare diseases induced by calcitriosis
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Génomique fonctionnelle et cancer
GERMANY
Mecklenburg-Vorpommern
ROSTOCK
Biomarker for Niemann Pick Type C Disease (NPC1/NPC2) an International, Multicenter, Epidemiological Study
Centogene AG
IRELAND
County Dublin
DUBLIN
AVERT: Autoimmunity Relapse Prediction Using Multiple Parallel Data Sources
Trinity College Dublin
Trinity Translational Medicine Institute
ITALY
FRIULI VENEZIA GIULIA
UDINE
Role of protein misfolding in the pathogenesis of Niemann-Pick type C disease: a possible therapeutic target
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Centro di Coordinamento Regionale per le Malattie Rare
ITALY
FRIULI VENEZIA GIULIA
UDINE
Screening of Niemann Pick type C among patients affected with psychiatric disease of unknown ethiology
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Centro di Coordinamento Regionale per le Malattie Rare
ITALY
LAZIO
ROMA
Targeting adenosine tone in Niemann Pick type C Disease
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
ITALY
LAZIO
ROMA
A novel pharmacological approach and identification of peripheral cellular biomarkers in Niemann-Pick C disease patients
ISS - Istituto Superiore di Sanità
Dipartimento del Farmaco
ITALY
PUGLIA
BARI
Physiopathology of HCV-related Cryoglobulinemic Vasculitis: molecular, immunological and clinical analisys
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica
ITALY
TOSCANA
PISA
Study of cellular mechanisms of neuronal dysfunction in Niemann Pick type C disease and identification of neuroprotective therapies
Fondazione "Gabriele Monasterio" - Consiglio Nazionale delle Ricerche CNR
Area della Ricerca
JAPAN
JAPAN
CHIBA
Pathological analysis and development ofan innovative therapeutic agent ofniemann-pick disease type C
Graduate School of Pharmaceutical Sciences, Chiba University
Laboratory of Chemical Pharmacology
JAPAN
JAPAN
KUMAMOTO
Developing new drugs for Niemann-Pick disease type C
Institute of Molecular Embryology and Genetics, Kumamoto University
Department of Cell Modulation
JAPAN
JAPAN
OSAKA
Developing the disease specific therapy for ANCA-associated vasculitis focused on immune regulatory factors in neutrophils
Osaka University Graduate School of Medicine
Department of Respiratory Medicine and Clinical Immunology
JAPAN
JAPAN
TOKYO
Multitiered study to address clinical questions for management of intractable vasculitides
Tokyo Women's Medical University
PORTUGAL
NORTE
PORTO
The sorting and trafficking of lysosomal proteins through M6P independent pathways: molecular, biochemical and functional studies
Instituto Nacional de Saúde Dr. Ricardo Jorge - Porto
Unidade de Investigação & Desenvolvimento; Departamento de Genética
SPAIN
Andalucía
GRANADA
Urinary biomarkers for the non-invasive diagnosis of kidney disease in systemic autoimmune diseases
GENYO - Genómica e Investigación Oncológica
Grupo de Genética de enfermedades complejas
SPAIN
Cataluña
BARCELONA
Corrective therapy of splicing by antisense oligonucleotides for Niemann-Pick disease type C: pre-clinical study in a murine model
Universitat de Barcelona. Facultat de Biologia
Departamento de genética molecular humana
UNITED KINGDOM
Glasgow
GLASGOW
Harnessing the power of integrated data to investigate environmental exposures on ANCA vasculitis risk, an unbiased approach -GB
Institute of Infection, Immunity and Inflammation, University of Glasgow
Institute of Infection, Immunity and Inflammation
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Therapeutics for rare and neglected diseases - science
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Development of neurosteroids for lysosomal storage disorders
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genetic analysis of complex inflammatory disorders
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genetic and genomic analysis of niemann pick type c1 disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genetics and pathophysiology of systemic onset juvenile idiopathic arthritis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Novel regulators of inflammatory arthritis and bone erosion
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Pathogenesis of behcet's disease and still's disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Clinical investigations of niemann-pick disease; type c
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Inborn errors of cholesterol synthesis
Institution: Information not provided - US
FRANCE
ILE-DE-FRANCE
PARIS
Model contribution in the microeconomic assessment of therapeutic strategies in Wegener granulomatosis
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de Santé publique : Gestion des risques et qualité
SPAIN
Cataluña
BARCELONA
Gene expression profile in CD4 + T lymphocytes of patients with eosinophilic granulomatosis with polyangiitis or Churg-Straus syndrome
Hospital Clínic de Barcelona
Servicio de Enfermedades Autoinmunes
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
STRIVE: A Long-Term, Multi-Center, Longitudinal Post-Marketing, Observational Registry to Assess Long Term Safety and Effectiveness of Humira (Adalimumab) in Children With Moderated to Severe Active Polyarticular or Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Institution: Information not provided - ES
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Nasal microbiome and host immunity in granulomatosis with polyangiitis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Characterization of proteins and other molecules by mass spectrometry
Institution: Information not provided - US
Multicentric Research projects
- UZ Leuven - Campus Gasthuisberg
- Coordinating centre of CF Network
- Institut de Biosciences et Biotechnologies de Grenoble (BIG) - CEA
- Laboratoire Biologie du Cancer et de l'Infection (BCI) - UMR 1036
- Faculté de médecine Paris-Descartes, Site Necker
- Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"
- Réseau Mucoviscidose de l'Association Française de recherche en kinésithérapie
- Medizinische Hochschule Hannover
- Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie
- IRCCS Ospedale San Raffaele
- Centro di Genomica, Bioinformatica e Biostatistica - Unità di Genetica Umana e Molecolare
- Ospedale San Giuseppe
- Il Polmone.it - Malattie Rare Polmonari
- University of Bristol
- Department of Physiology and Pharmacology
- Department of Health
- Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
- Christiane Herzog Ambulanz
- Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
- Christiane Herzog Ambulanz
- Centre Chirurgical Marie Lannelongue
- Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique - Inserm UMR_S 999
- Fondazione IRCCS Policlinico San Matteo
- S.C. di Pneumologia
- Queen's University
- Department of Biomedical and Molecular Sciences
- Faculté de médecine - RTH Laënnec
- Métabolomique et maladies métaboliques
- CHU Dijon Bourgogne - Hôpital François Mitterrand
- Service de Pneumologie - Soins Intensifs, Appareillage Respiratoire
- Institut Cochin (INSERM U 1016 - CNRS UMR 8104)
- Département Génétique et Développement
- Med. Klinik und Poliklinik II des UKGM am Standort Gießen
- Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen
- Medizinische Hochschule Hannover
- Klinik für Pneumologie
- Istituto San Raffaele Telethon per la Terapia Genica - TIGET
- Unità di Ricerca Clinica
- Istituto San Raffaele Telethon per la Terapia Genica - TIGET
- Unità di Ricerca Clinica
- Medizinische Universität Wien
- Klinisches Institut für Pathologie
- Institut für Immunologie der Universität Münster
- Institut für Immunologie
- Hospital Clínico Universitario de Santiago
- Servicio de Reumatología
BELGIUM
VLAAMS BRABANT
LEUVEN
European Cystic Fibrosis Thematic Network
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
B9inPAH: BMP9 as a major regulator of vascular tone in Pulmonary Arterial Hypertension: a promising new therapeutic target
FRANCE
ILE-DE-FRANCE
PARIS
NEUPROCF: nouveau diagnostic et biomarqueurs pronostics de la mucoviscidose (TERMINE)
FRANCE
PROVENCE-ALPES-COTE D'AZUR
CANNES
Réseau Mucoviscidose-Bronchiolite pour l'étude, la recherche, la prévention en kinesithérapie respiratoire et cardio-vasculaire
GERMANY
Niedersachsen
HANNOVER
INSTINCT: Induced pluripotent stem cells for identification of novel drug combinations targeting cystic fibrosis lung and liver disease
ITALY
LOMBARDIA
MILANO
RescueCFTRpreclinic: Cysteamine for the treatment of cystic fibrosis: a translational research project
ITALY
LOMBARDIA
MILANO
Il Polmone.it - Malattie Rare Polmonari
UNITED KINGDOM
Avon
BRISTOL
EUROCARE CF: European coordination action for research in cystic fibrosis
UNITED KINGDOM
Greater London
LONDON
RASopathy network: disorders of the Ras-MAPK pathway
GERMANY
Bayern
MÜNCHEN
CHILD-EU: Orphans Unite: chILD better together European Management Platform for Childhood Interstitial Lung Diseases
GERMANY
Bayern
MÜNCHEN
HCQ4Surfdefect : Hydroxychloroquine (HCQ) in pediatric ILD
FRANCE
ILE-DE-FRANCE
LE PLESSIS-ROBINSON
TAMIRAH : Targeting activated mineralocorticoid receptor in Pulmonary Arterial Hypertension: A translational approach towards treatment
ITALY
LOMBARDIA
PAVIA
EuPAPNet: European pulmonary alveolar proteinosis network: molecular determinants of causes, variability and outcome
CANADA
Ontario
KINGSTON
IIH-ECC: Idiopathic Infantile Hypercalcemia: European-Canadian Consortium
FRANCE
AUVERGNE-RHONE-ALPES
LYON
Réseau sur les maladies de surcharge lysosomales
FRANCE
BOURGOGNE-FRANCHE-COMTE
DIJON
SHOT-IPF: Small HSPs Inhibitors to Treat Idiopathic Pulmonary Fibrosis
FRANCE
ILE-DE-FRANCE
PARIS
EUROAS: European consortium for the genetic and immunogenetic studies of spondylarthrite ankylosante and other spondylarthropathies
GERMANY
Hessen
GIEßEN
eurIPFnet: European IPF network: natural course, pathomechanisms and novel treatment options in idiopathic pulmonary fibrosis
GERMANY
Niedersachsen
HANNOVER
IPF-AE: Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Mechanism and Biomarkers
ITALY
LOMBARDIA
MILANO
EURO-CGD: genetics and pathogenesis of chronic granulomatous disease and development of new gene transfer therapeutic approaches
ITALY
LOMBARDIA
MILANO
CELL-PID: advanced cell-based therapies for the treatment of primary immunodeficiency
AUSTRIA
WIEN
WIEN
RELENT: RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities
GERMANY
Nordrhein-Westfalen
MÜNSTER
Treat-AID : New treatments for auto-inflammatory diseases
SPAIN
Galicia
SANTIAGO DE COMPOSTELA